Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis

Journal of Neurochemistry

Volumn 114, Issue 3, 2010, Pages 921-932

  Caruso, Donatella ^a   D'Intino, Giulia ^b   Giatti, Silvia ^a   Maschi, Omar ^a   Pesaresi, Marzia ^a   Calabrese, Donato ^a   Garcia Segura, Luis Miguel ^c   Calza, Laura ^b   Melcangi, Roberto C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INSTITUTO CAJAL   (Spain)

Author keywords

liquid chromatography tandem mass spectrometry; multiple sclerosis; neurosteroids; progesterone; steroid metabolism; testosterone

Indexed keywords

NEUROSTEROID; PREGNENOLONE; PROGESTERONE; TESTOSTERONE; SEX HORMONE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DEMYELINATION; DISABILITY; FEMALE; LIQUID CHROMATOGRAPHY; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SPINAL CORD; STEROID METABOLISM; TANDEM MASS SPECTROMETRY; ANIMAL; CHRONIC DISEASE; DISEASE MODEL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GUINEA PIG; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; SEXUAL DEVELOPMENT;

RATTUS;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GONADAL STEROID HORMONES; GUINEA PIGS; MALE; MULTIPLE SCLEROSIS; RATS; SEX CHARACTERISTICS;

EID: 77954341841     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06825.x     Document Type: Article

References (66)

1. Backstrom T., Wahlstrom G., Wahlstrom K., Zhu D. Wang M. D. (2005) Isoallopregnanolone; an antagonist to the anaesthetic effect of allopregnanolone in male rats. Eur. J. Pharmacol. 512, 15 21.
2. Barreto G., Veiga S., Azcoitia I., Garcia-Segura L. M. Garcia-Ovejero D. (2007) Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur. J. Neurosci. 25, 3039 3046.
3. Bitran D., Hilvers R. J. Kellogg C. K. (1991) Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res. 561, 157 161.
4. van den Broek H. H., Damoiseaux J. G., De Baets M. H. Hupperts R. M. (2005) The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review. Mult. Scler. 11, 349 359.
5. Cabrelle A., Dell'Aica I., Melchiori L. et al. (2008) Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease. J. Leukoc. Biol. 83, 212 219.
6. Calza L., Giardino L., Pozza M., Micera A. Aloe L. (1997) Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis. Proc. Natl Acad. Sci. USA 94, 3368 3373.
7. Calza L., Fernandez M., Giuliani A., Aloe L. Giardino L. (2002) Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proc. Natl Acad. Sci. USA 99, 3258 3263.
8. Calza L., Fernandez M., Giuliani A., D'Intino G., Pirondi S., Sivilia S., Paradisi M., Desordi N. Giardino L. (2005) Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease. Brain Res. Brain Res. Rev. 48, 339 346.
9. Caruso D., Scurati S., Maschi O., De Angelis L., Roglio I., Giatti S., Garcia-Segura L. M. Melcangi R. C. (2008) Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem. Int. 52, 560 568.
10. Ciriza I., Carrero P., Frye C. A. Garcia-Segura L. M. (2006) Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J. Neurobiol. 66, 916 928.
11. Confavreux C., Vukusic S. Adeleine P. (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126, 770 782.
12. Dalal M., Kim S. Voskuhl R. R. (1997) Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159, 3 6.
13. Darlington C. (2002) Multiple sclerosis and gender. Curr. Opin. Investig. Drugs 3, 911 914.
14. Drew P. D. Chavis J. A. (2000) Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol. 111, 77 85.
15. El-Etr M., Vukusic S., Gignoux L., Durand-Dubief F., Achiti I., Baulieu E. E. Confavreux C. (2005) Steroid hormones in multiple sclerosis. J. Neurol. Sci. 233, 49 54.
16. Fargo K. N., Foecking E. M., Jones K. J. Sengelaub D. R. (2009) Neuroprotective actions of androgens on motoneurons. Front. Neuroendocrinol. 30, 130 141.
17. Fernandez M., Giuliani A., Pirondi S., D'Intino G., Giardino L., Aloe L., Levi-Montalcini R. Calza L. (2004) Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc. Natl Acad. Sci. USA 101, 16363 16368.
18. Foster S. C., Daniels C., Bourdette D. N. Bebo Jr. B. F. (2003) Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neuroimmunol. 140, 78 87.
19. Foster C. A., Mechtcheriakova D., Storch M. K. et al. (2009) FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol. 19, 254 266.
20. Franklin R. J. Ffrench-Constant C. (2008) Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839 855.
21. Frye C. A., Van Keuren K. R. Erskine M. S. (1996) Behavioral effects of 3 alpha-androstanediol. I: modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav. Brain Res. 79, 109 118.
22. Gago N., Akwa Y., Sananes N., Guennoun R., Baulieu E. E., El-Etr M. Schumacher M. (2001) Progesterone and the oligodendroglial lineage: stage-dependent biosynthesis and metabolism. Glia 36, 295 308.
23. Ganter S., Northoff H., Mannel D. Gebicke-Harter P. J. (1992) Growth control of cultured microglia. J. Neurosci. Res. 33, 218 230.
24. Garay L., Deniselle M. C., Lima A., Roig P. De Nicola A. F. (2007) Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J. Steroid Biochem. Mol. Biol. 107, 228 237.
25. Garay L., Gonzalez Deniselle M. C., Gierman L., Meyer M., Lima A., Roig P. De Nicola A. F. (2008) Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 15, 76 83.
26. Garcia-Estrada J., Del Rio J. A., Luquin S., Soriano E. Garcia-Segura L. M. (1993) Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res. 628, 271 278.
27. Gee K. W., Bolger M. B., Brinton R. E., Coirini H. McEwen B. S. (1988) Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 246, 803 812.
28. Ghoumari A. M., Ibanez C., El-Etr M., Leclerc P., Eychenne B., O'Malley B. W., Baulieu E. E. Schumacher M. (2003) Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 86, 848 859.
29. Ghoumari A. M., Baulieu E. E. Schumacher M. (2005) Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 135, 47 58.
30. Giatti S., D'Intino G., Maschi O., Pesaresi M., Garcia-Segura L. M., Calza L., Caruso D. Melcangi R. C. (2010) Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochem. Int. 56, 118 127.
31. Gold R., Linington C. Lassmann H. (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953 1971.
32. Hauser S. L. Oksenberg J. R. (2006) The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52, 61 76.
33. Hoffman G. E., Le W. W., Murphy A. Z. Koski C. L. (2001) Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats. Exp. Neurol. 171, 272 284.
34. Holmqvist P., Wallberg M., Hammar M., Landtblom A. M. Brynhildsen J. (2006) Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 54, 149 153.
35. Houzen H., Niino M., Kikuchi S., Fukazawa T., Nogoshi S., Matsumoto H. Tashiro K. (2003) The prevalence and clinical characteristics of MS in northern Japan. J. Neurol. Sci. 211, 49 53.
36. Ibanez C., Shields S. A., El-Etr M., Baulieu E. E., Schumacher M. Franklin R. J. (2004) Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol. Appl. Neurobiol. 30, 80 89.
37. Jones K. J., Coers S., Storer P. D., Tanzer L. Kinderman N. B. (1999) Androgenic regulation of the central glia response following nerve damage. J. Neurobiol. 40, 560 573.
38. Labombarda F., Gonzalez S., Gonzalez Deniselle M. C., Garay L., Guennoun R., Schumacher M. De NIcola A. F. (2006) Progesterone increases the expression of myelin basic protein and the number of cells showing NG2 immunostaining in the lesioned spinal cord. J. Neurotrauma 23, 181 192.
39. Labombarda F., Gonzalez S. L., Lima A. Roig P. (2009) Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 57, 884 897.
40. Lambert J. J., Belelli D., Peden D. R., Vardy A. W. Peters J. A. (2003) Neurosteroid modulation of GABAA receptors. Prog. Neurobiol. 71, 67 80.
41. Leitner H. (2010) Influence of neurosteroids on the pathogenesis of multiple sclerosis. Med. Hypotheses doi
42. Lorentzen J. C., Issazadeh S., Storch M., Mustafa M. I., Lassman H., Linington C., Klareskog L. Olsson T. (1995) Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. J. Neuroimmunol. 63, 193 205.
43. Lorenzini L., Giuliani A., Giardino L. Calzà L. (2010) Laser acupuncture for acute inflammatory, visceral and neuropathic pain relief: an experimental study in the laboratory rat. Res. Vet. Sci. 88, 159 165.
44. Lundgren P., Stromberg J., Backstrom T. Wang M. (2003) Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta-hydroxy-5alpha-pregnan-20-one (isoallopregnanolone). Brain Res. 982, 45 53.
45. Maccio D. R., Calfa G., Volosin M. Roth G. A. (2004) Serum testosterone and corticosterone levels in acute experimental autoimmune encephalomyelitis (EAE) in male Wistar rats. Neuro Endocrinol. Lett. 25, 196 200.
46. Marin-Husstege M., Muggironi M., Raban D., Skoff R. P. Casaccia-Bonnefil P. (2004) Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev. Neurosci. 26, 245 254.
47. Melcangi R. C. Garcia-Segura L. M. (2010) Sex-specific therapeutic strategies based on neuroactive steroids: in search for innovative tools for neuroprotection. Horm. Behav. 57, 2 11.
48. Merrill J. E., Hanak S., Pu S. F., Liang J., Dang C., Iglesias-Bregna D., Harvey B., Zhu B. McMonagle-Strucko K. (2009) Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis. J. Neurol. 256, 89 103.
49. Momcilovic M., Miljkovic Z., Popadic D., Miljkovic D. Mostarica-Stojkovic M. (2008) Kinetics of IFN-gamma and IL-17 expression and production in active experimental autoimmune encephalomyelitis in Dark Agouti rats. Neurosci. Lett. 447, 148 152.
50. Muller E. Kerschbaum H. H. (2006) Progesterone and its metabolites 5-dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2. Neuro Endocrinol. Lett. 27, 675 678.
51. Nicot A. (2009) Gender and sex hormones in multiple sclerosis pathology and therapy. Front. Biosci. 14, 4477 4515.
52. Noonan C. W., Kathman S. J. White M. C. (2002) Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 58, 136 138.
53. Orton S. M., Herrera B. M., Yee I. M., Valdar W., Ramagopalan S. V., Sadovnick A. D. Ebers G. C. (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 5, 932 936.
54. Papadopoulos D., Pham-Dinh D. Reynolds R. (2006) Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp. Neurol. 197, 373 385.
55. Pelfrey C. M., Moldovan I. R., Cotleur A. C., Zamor N. Rudick R. A. (2005) Effects of sex hormones on costimulatory molecule expression in multiple sclerosis. J. Neuroimmunol. 167, 190 203.
56. Pesaresi M., Maschi O., Giatti S., Garcia-Segura L. M., Caruso D. Melcangi R. C. (2010a) Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm. Behav. 57, 46 55.
57. Pesaresi M., Giatti S., Calabrese D., Maschi O., Caruso D. Melcangi R. C. (2010b) Dihydroprogesterone increases the gene expression of myelin basic protein in spinal cord of diabetic rats. J. Mol. Neurosci. doi
58. Pozzilli C., Tomassini V., Marinelli F., Paolillo A., Gasperini C. Bastianello S. (2003) 'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence. Eur. J. Neurol. 10, 95 97.
59. Safarinejad M. R. (2008) Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis. J. Neuroendocrinol. 20, 1368 1375.
60. Schwendimann R. N. Alekseeva N. (2007) Gender issues in multiple sclerosis. Int. Rev. Neurobiol. 79, 377 392.
61. Tomassini V. Pozzilli C. (2006) Sex hormones: a role in the control of multiple sclerosis? Expert Opin. Pharmacother. 7, 857 868.
62. Tomassini V., Onesti E., Mainero C., Giugni E., Paolillo A., Salvetti M., Nicoletti F. Pozzilli C. (2005) Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J. Neurol. Neurosurg. Psychiatry 76, 272 275.
63. Voskuhl R. R. Palaszynski K. (2001) Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7, 258 270.
64. Vukusic S. Confavreux C. (2006) Pregnancy and multiple sclerosis: the children of PRIMS. Clin. Neurol. Neurosurg. 108, 266 270.
65. Vukusic S., Hutchinson M., Hours M., Moreau T., Cortinovis-Tourniaire P., Adeleine P., Confavreux C. and The Pregnancy In Multiple Sclerosis G. (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127, 1353 1360.
66. Wang M., He Y., Eisenman L. N. et al. (2002) 3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J. Neurosci. 22, 3366 3375.